Published in Mayo Clin Proc on October 01, 1999
Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin Proc (2009) 1.33
Personality-informed interventions for healthy aging: conclusions from a National Institute on Aging work group. Dev Psychol (2013) 1.25
Psychological factors and cardiac risk and impact of exercise training programs-a review of ochsner studies. Ochsner J (2007) 0.80
The russert impact: a golden opportunity to promote primary coronary prevention. Ochsner J (2008) 0.80
Anhedonia is associated with poor health status and more somatic and cognitive symptoms in patients with coronary artery disease. Qual Life Res (2010) 0.79
Wisconsin rural women's health study psychological factors and blood cholesterol level: difference between normal and overweight rural women. Clin Med Res (2004) 0.79
Personality and actigraphy-measured physical activity in older adults. Psychol Aging (2017) 0.79
Preventive cardiology and non-invasive cardiology research at the ochsner clinic foundation. Ochsner J (2006) 0.78
Multifactorial approach to the primary and secondary prevention of atherosclerosis. Ochsner J (2003) 0.76
Does the effect of supervised cardiac rehabilitation programs on body fat distribution remained long time? J Cardiovasc Thorac Res (2013) 0.75
Hostility and cardiac rehabilitation. Mayo Clin Proc (2000) 0.75
The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol (2000) 2.23
Renin-angiotensin system: genes to bedside. Am Heart J (1997) 2.06
Effects of cardiac rehabilitation and exercise training in obese patients with coronary artery disease. Chest (1996) 1.64
Factors predicting improvements in lipid values following cardiac rehabilitation and exercise training. Arch Intern Med (1993) 1.43
Valvular regurgitation and right-sided cardiac pressures in heart transplant recipients by complete Doppler and color flow evaluation. Chest (1993) 1.40
Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol (1997) 1.36
Effects of cardiac rehabilitation and exercise training programs in women with depression. Am J Cardiol (1999) 1.19
Benefits of cardiac rehabilitation and exercise training in secondary coronary prevention in the elderly. J Am Coll Cardiol (1993) 1.04
Effects of cardiac rehabilitation and exercise training on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in women. Am J Cardiol (1995) 1.00
Effects of cardiac rehabilitation programs on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in a large elderly cohort. Am J Cardiol (1995) 1.00
Effects of cardiac rehabilitation and exercise training on low-density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease. Am J Cardiol (1994) 0.95
Disparate effects of improving aerobic exercise capacity and quality of life after cardiac rehabilitation in young and elderly coronary patients. J Cardiopulm Rehabil (2000) 0.94
Obesity and the "obesity paradox" in cardiovascular diseases. Clin Pharmacol Ther (2011) 0.92
Effects of cardiac rehabilitation and exercise programs on exercise capacity, coronary risk factors, behavior, and quality of life in patients with coronary artery disease. South Med J (1997) 0.89
Prognostic value of stress echocardiography in the evaluation of atypical chest pain patients without known coronary artery disease. Am J Cardiol (1998) 0.88
Benefits of cardiac rehabilitation and exercise training in elderly women. Am J Cardiol (1997) 0.87
Benefits of cardiac rehabilitation and exercise training. Chest (2000) 0.87
Patients with high baseline exercise capacity benefit from cardiac rehabilitation and exercise training programs. Am Heart J (1994) 0.86
Cyclosporine-induced hypertension. Efficacy of omega-3 fatty acids in patients after cardiac transplantation. Circulation (1993) 0.86
Modulatory impact of cardiac rehabilitation on hyperhomocysteinemia in patients with coronary artery disease and "normal" lipid levels. Am J Cardiol (1998) 0.83
Marked benefit with sustained-release niacin therapy in patients with "isolated" very low levels of high-density lipoprotein cholesterol and coronary artery disease. Am J Cardiol (1992) 0.83
Exercise and the heart: risks, benefits, and recommendations for providing exercise prescriptions. Ochsner J (2001) 0.83
Effects of nonpharmacologic therapy with cardiac rehabilitation and exercise training in patients with low levels of high-density lipoprotein cholesterol. Am J Cardiol (1996) 0.82
Effects of aerobic exercise training on indices of ventricular repolarization in patients with chronic heart failure. Chest (1999) 0.82
Predicting prognosis in advanced heart failure. Use of exercise indices. Chest (1996) 0.81
Effects of cardiac rehabilitation and exercise training programs in patients > or = 75 years of age. Am J Cardiol (1996) 0.81
Study of arterial and autonomic effects of cyclosporine in humans. Hypertension (2000) 0.80
National Cholesterol Education Program's recommendations, and implications of "missing" high-density lipoprotein cholesterol in cardiac rehabilitation programs. Am J Cardiol (1991) 0.80
Exercise and the heart. Good, benign, or evil? Postgrad Med (1992) 0.79
Effects of cardiac rehabilitation and exercise training on peak aerobic capacity and work efficiency in obese patients with coronary artery disease. Am J Cardiol (1999) 0.79
Benefits of cardiac rehabilitation and exercise training programs in elderly coronary patients. Am J Geriatr Cardiol (2001) 0.79
Emphasis on high-density lipoprotein cholesterol in patients with coronary artery disease. South Med J (1993) 0.79
Usefulness of peak oxygen consumption in predicting outcome of heart failure in women versus men. Am J Cardiol (1997) 0.79
Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control. J Heart Lung Transplant (1997) 0.78
Safety and side effects of sustained-release niacin. JAMA (1994) 0.78
Prevention and reduction of left ventricular hypertrophy in the elderly. Clin Geriatr Med (1996) 0.77
Update on new coronary risk factors. Chest (1996) 0.77
Cardiac rehabilitation, exercise training, and preventive cardiology research at Ochsner Heart and Vascular Institute. Tex Heart Inst J (1995) 0.77
Doppler echocardiographic assessment of valvular heart disease in patients requiring hemodialysis for end-stage renal disease. South Med J (1995) 0.77
Lipid-lowering therapy and long-term survival in heart transplantation. Am J Cardiol (1997) 0.76
Do statins cause or prevent dementia? Eur J Neurol (2014) 0.76
Cardiac rehabilitation and health-care reform. Chest (1995) 0.76
Niacin in patients with diabetes mellitus and coronary artery disease. Am J Cardiol (2001) 0.76
Cardiac rehabilitation and preventive cardiology in the elderly. Cardiol Clin (1999) 0.76
Effect of immunosuppressive regimen on novel markers of atherothrombosis in heart transplantation: homocysteine, c-reactive protein, and mean platelet volume. Transplant Proc (2002) 0.76
Vitamin D status, left ventricular geometric abnormalities and cardiovascular disease. J Intern Med (2012) 0.76
Smoking cessation: the importance of medical intervention. Ochsner J (1999) 0.76
Comparison of the efficacy and safety of pravastatin and simvastatin in heart transplantation. J Assoc Physicians India (2002) 0.75
Stable ischemic heart disease. Using stress and imaging procedures to direct therapy. Postgrad Med (1996) 0.75
Prevention of atherosclerosis. The potential role of antioxidants. Postgrad Med (1995) 0.75
Ventricular-vascular uncoupling increases expression of B-type natriuretic peptide in heart transplantation. Transplant Proc (2004) 0.75